Contraception for young women with focus on long-acting, reversible contraceptives
Long-acting, reversible contraceptives are about 20 times more effective in terms of contraceptive efficacy than oral hormonal contraceptives, patch or vaginal ring are. Long-acting, reversible contraceptives are not associated with serious adverse events but induce changes in menstrual bleeding pattern in about 75% of the users. The progestogen intrauterine device is effective in the treatment of menor-rhagia and dysmenorrhoea. Increased use of long-acting reversible contraceptives is expected to reduce unplanned pregnancies and legal abortions in all ages. Concomitant use of barrier methods is important to prevent sexually transmitted diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:179 |
---|---|
Enthalten in: |
Ugeskrift for laeger - 179(2017), 23 vom: 13. Nov. |
Sprache: |
Dänisch |
---|
Beteiligte Personen: |
Ravn, Pernille [VerfasserIn] |
---|
Themen: |
5W7SIA7YZW |
---|
Anmerkungen: |
Date Completed 19.12.2018 Date Revised 19.12.2018 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM278058701 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM278058701 | ||
003 | DE-627 | ||
005 | 20231225015707.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2017 xx |||||o 00| ||dan c | ||
028 | 5 | 2 | |a pubmed24n0926.xml |
035 | |a (DE-627)NLM278058701 | ||
035 | |a (NLM)29139352 | ||
035 | |a (PII)V04170314 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a dan | ||
100 | 1 | |a Ravn, Pernille |e verfasserin |4 aut | |
245 | 1 | 0 | |a Contraception for young women with focus on long-acting, reversible contraceptives |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.12.2018 | ||
500 | |a Date Revised 19.12.2018 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Long-acting, reversible contraceptives are about 20 times more effective in terms of contraceptive efficacy than oral hormonal contraceptives, patch or vaginal ring are. Long-acting, reversible contraceptives are not associated with serious adverse events but induce changes in menstrual bleeding pattern in about 75% of the users. The progestogen intrauterine device is effective in the treatment of menor-rhagia and dysmenorrhoea. Increased use of long-acting reversible contraceptives is expected to reduce unplanned pregnancies and legal abortions in all ages. Concomitant use of barrier methods is important to prevent sexually transmitted diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Contraceptive Agents, Female |2 NLM | |
650 | 7 | |a Drug Implants |2 NLM | |
650 | 7 | |a Levonorgestrel |2 NLM | |
650 | 7 | |a 5W7SIA7YZW |2 NLM | |
650 | 7 | |a Desogestrel |2 NLM | |
650 | 7 | |a 81K9V7M3A3 |2 NLM | |
650 | 7 | |a Medroxyprogesterone Acetate |2 NLM | |
650 | 7 | |a C2QI4IOI2G |2 NLM | |
700 | 1 | |a Petersen, Kresten Rubeck |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ugeskrift for laeger |d 1945 |g 179(2017), 23 vom: 13. Nov. |w (DE-627)NLM000011185 |x 1603-6824 |7 nnns |
773 | 1 | 8 | |g volume:179 |g year:2017 |g number:23 |g day:13 |g month:11 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 179 |j 2017 |e 23 |b 13 |c 11 |